VIVUS, Inc.
(NASDAQ : VVUS)

( )
VVUS PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
VRXValeant Pharmaceuticals International, Inc.
-10.75%19.6814.1%$423.46m
SAGESAGE Therapeutics, Inc.
-4.02%158.0310.9%$226.59m
SHPGShire PLC Sponsored ADR
-0.08%147.200.4%$159.41m
PRGOPerrigo Co. Plc
-2.27%84.076.6%$82.08m
MNKMallinckrodt Plc
-3.10%23.1218.5%$78.88m
GWPHGW Pharmaceuticals PLC Sponsored ADR
5.52%130.827.6%$60.16m
JAZZJazz Pharmaceuticals Plc
-3.65%135.502.2%$53.33m
UTHRUnited Therapeutics Corporation
-0.37%135.7814.5%$51.60m
ICPTIntercept Pharmaceuticals, Inc.
-4.03%61.6122.0%$38.01m
RVNCRevance Therapeutics, Inc.
-5.72%32.1512.2%$36.25m
MDCOMedicines Company
-1.45%27.2522.1%$35.42m
ENDPEndo International Plc
0.00%7.818.9%$32.98m
CTLTCatalent Inc
0.08%40.052.6%$31.80m
ADMSAdamas Pharmaceuticals, Inc.
-3.81%32.0816.9%$31.56m
PTLAPortola Pharmaceuticals, Inc.
-3.73%47.557.8%$30.99m

Company Profile

VIVUS, Inc. engages in the development and commercialization of novel therapeutic products. Its products include Qsymia and STENDRA/SPEDRA. The company was founded by Virgil A. Palace in April 16, 1991 and is headquartered in Mountain View, CA.